InsiderTrades

Form 4 for KURA Kura Oncology, Inc.

Accepted 2023-02-21 00:00:00 ET · period of report 2022-07-14 · accession 0001209191-23-011276 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2023-02-21 2022-07-14+ KURA WILSON TROY EDWARD Pres, CEO, Dir J - Other $0.00 -486.0K 1.15M -30% $0
D 2023-02-21 2022-08-19 KURA WILSON TROY EDWARD Pres, CEO, Dir J - Other $0.00 -12.0K 30.5K -28% $0
D 2023-02-21 2023-02-16 KURA WILSON TROY EDWARD Pres, CEO, Dir A - Grant $0.00 +560.0K 560.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-19 J D 41,318 $0.00 1,092,694 I by Red Fish Blue Fish Revocable Trust — —
2 Common Common Stock 2022-08-19 J D 11,985 $0.00 30,525 D — — (F3) Includes 1,109 shares acquired on November 17, 2021 and 1,450 shares acquired on May 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
3 Common Common Stock 2022-10-06 J A 1,084,300 $0.00 1,125,618 I by One Fish Two Fish Revocable Trust — —
4 Common Common Stock 2022-10-06 J D 1,084,300 $0.00 8,394 I by Red Fish Blue Fish Revocable Trust — —
5 Common Common Stock 2022-08-19 J A 41,318 $0.00 41,318 I by One Fish Two Fish Revocable Trust — —
6 Common Common Stock 2022-08-19 J D 17,708 $0.00 1,134,012 I by Red Fish Blue Fish Revocable Trust — —
7 Common Common Stock 2022-07-14 J D 468,297 $0.00 1,151,720 I by Red Fish Blue Fish Revocable Trust — —
8 Derivative Option to purchase common stock 2023-02-16 A A 560,000 $0.00 560,000 D $11.99 · — to 2033-02-15 560,000 Common Stock (F4) This option vests in 48 equal monthly installments commencing on the grant date.